Toll Free: 1-888-928-9744

United States Chronic Kidney Disease Drug Industry 2016 Market Research Report

Published: Jun 20, 2016 | Pages: 131 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The United States Chronic Kidney Disease Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Chronic Kidney Disease Drug industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Chronic Kidney Disease Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Chronic Kidney Disease Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


 Table of Contents
1 Industry Overview 1.1 Definition and Specifications of Chronic Kidney Disease Drug 1.1.1 Definition of Chronic Kidney Disease Drug 1.1.2 Specifications of Chronic Kidney Disease Drug 1.2 Classification of Chronic Kidney Disease Drug 1.3 Applications of Chronic Kidney Disease Drug 1.4 Industry Chain Structure of Chronic Kidney Disease Drug 1.5 Industry Overview of Chronic Kidney Disease Drug 1.6 Industry Policy Analysis of Chronic Kidney Disease Drug 1.7 Industry News Analysis of Chronic Kidney Disease Drug 2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug 2.1 Bill of Materials (BOM) of Chronic Kidney Disease Drug 2.2 BOM Price Analysis of Chronic Kidney Disease Drug 2.3 Labor Cost Analysis of Chronic Kidney Disease Drug 2.4 Depreciation Cost Analysis of Chronic Kidney Disease Drug 2.5 Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug 2.6 Manufacturing Process Analysis of Chronic Kidney Disease Drug 2.7 United States Price, Cost and Gross of Chronic Kidney Disease Drug 2011-2016 3 Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015 3.2 Manufacturing Plants Distribution of United States Key Chronic Kidney Disease Drug Manufacturers in 2015 3.3 R&D Status and Technology Source of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 3.4 Raw Materials Sources Analysis of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 4 Production Analysis of Chronic Kidney Disease Drug by Regions, Type, and Applications 4.1 United States Production of Chronic Kidney Disease Drug by Regions 2011-2016 4.2 United States Production of Chronic Kidney Disease Drug by Type 2011-2016 4.3 United States Sales of Chronic Kidney Disease Drug by Applications 2011-2016 4.4 Price Analysis of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Chronic Kidney Disease Drug 2011-2016 5 Consumption Volume and Consumption Value Analysis of Chronic Kidney Disease Drug by Regions 5.1 United States Consumption Volume of Chronic Kidney Disease Drug by Regions 2011-2016 5.2 United States Consumption Value of Chronic Kidney Disease Drug by Regions 2011-2016 5.3 United States Consumption Price Analysis of Chronic Kidney Disease Drug by Regions 2011-2016 6 Analysis of Chronic Kidney Disease Drug Production, Supply, Sales and Market Status 2011-2016 6.1 Capacity, Production, Sales, and Revenue of Chronic Kidney Disease Drug 2011-2016 6.2 Production Market Share and Sales Market Share Analysis of Chronic Kidney Disease Drug 2014-2015 6.3 Sales Overview of Chronic Kidney Disease Drug 2011-2016 6.4 Supply, Consumption and Gap of Chronic Kidney Disease Drug 2011-2016 6.5 Import, Export and Consumption of Chronic Kidney Disease Drug 2011-2016 6.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease Drug 2011-2016 7 Analysis of Chronic Kidney Disease Drug Industry Key Manufacturers 7.1 Actavis PLC 7.1.1 Company Profile 7.1.2 Product Picture and Specifications 7.1.2.1 Type I 7.1.2.2 Type II 7.1.2.3 Type III 7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 7.1.4 Contact Information 7.2 Amgen Inc. 7.2.1 Company Profile 7.2.2 Product Picture and Specifications 7.2.2.1 Type I 7.2.2.2 Type II 7.2.2.3 Type III 7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 7.2.4 Contact Information 7.3 Johnson & Johnson 7.3.1 Company Profile 7.3.2 Product Picture and Specifications 7.3.2.1 Type I 7.3.2.2 Type II 7.3.2.3 Type III 7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 7.3.4 Contact Information 7.4 F. Hoffmann-La Roche Ltd 7.4.1 Company Profile 7.4.2 Product Picture and Specifications 7.4.2.1 Type I 7.4.2.2 Type II 7.4.2.3 Type III 7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 7.4.4 Contact Information 7.5 Sanofi 7.5.1 Company Profile 7.5.2 Product Picture and Specifications 7.5.2.1 Type I 7.5.2.2 Type II 7.5.2.3 Type III 7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 7.5.4 Contact Information 7.6 Abbott Laboratories 7.6.1 Company Profile 7.6.2 Product Picture and Specifications 7.6.2.1 Type I 7.6.2.2 Type II 7.6.2.3 Type III 7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 7.6.4 Contact Information 7.7 Akebia Therapeutics 7.7.1 Company Profile 7.7.2 Product Picture and Specifications 7.7.2.1 Type I 7.7.2.2 Type II 7.7.2.3 Type III 7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 7.7.4 Contact Information 7.8 AMAG Pharmaceuticals 7.8.1 Company Profile 7.8.2 Product Picture and Specifications 7.8.2.1 Type I 7.8.2.2 Type II 7.8.2.3 Type III 7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 7.8.4 Contact Information 7.9 Cara Therapeutics 7.9.1 Company Profile 7.9.2 Product Picture and Specifications 7.9.2.1 Type I 7.9.2.2 Type II 7.9.2.3 Type III 7.9.3 Capacity, Production, Price, Cost, Gross and Revenue 7.9.4 Contact Information 7.10 FibroGen 7.10.1 Company Profile 7.10.2 Product Picture and Specifications 7.10.2.1 Type I 7.10.2.2 Type II 7.10.2.3 Type III 7.10.3 Capacity, Production, Price, Cost, Gross and Revenue 7.10.4 Contact Information 7.11 Keryx Biopharmaceuticals 7.11.1 Company Profile 7.11.2 Product Picture and Specifications 7.11.2.1 Type I 7.11.2.2 Type II 7.11.2.3 Type III 7.11.3 Capacity, Production, Price, Cost, Gross and Revenue 7.11.4 Contact Information 7.12 Reata Pharmaceuticals 7.12.1 Company Profile 7.12.2 Product Picture and Specifications 7.12.2.1 Type I 7.12.2.2 Type II 7.12.2.3 Type III 7.12.3 Capacity, Production, Price, Cost, Gross and Revenue 7.12.4 Contact Information 7.13 OPKO Health 7.13.1 Company Profile 7.13.2 Product Picture and Specifications 7.13.2.1 Type I 7.13.2.2 Type II 7.13.2.3 Type III 7.13.3 Capacity, Production, Price, Cost, Gross and Revenue 7.13.4 Contact Information 7.14 Pharmacosmos 7.14.1 Company Profile 7.14.2 Product Picture and Specifications 7.14.2.1 Type I 7.14.2.2 Type II 7.14.2.3 Type III 7.14.3 Capacity, Production, Price, Cost, Gross and Revenue 7.14.4 Contact Information 7.15 Raptor Pharmaceuticals 7.15.1 Company Profile 7.15.2 Product Picture and Specifications 7.15.2.1 Type I 7.15.2.2 Type II 7.15.2.3 Type III 7.15.3 Capacity, Production, Price, Cost, Gross and Revenue 7.15.4 Contact Information 7.16 Regulus Therapeutics 7.16.1 Company Profile 7.16.2 Product Picture and Specifications 7.16.2.1 Type I 7.16.2.2 Type II 7.16.2.3 Type III 7.16.3 Capacity, Production, Price, Cost, Gross and Revenue 7.16.4 Contact Information 7.17 Rockwell Medical 7.17.1 Company Profile 7.17.2 Product Picture and Specifications 7.17.2.1 Type I 7.17.2.2 Type II 7.17.2.3 Type III 7.17.3 Capacity, Production, Price, Cost, Gross and Revenue 7.17.4 Contact Information 7.18 Shield Therapeutics 7.18.1 Company Profile 7.18.2 Product Picture and Specifications 7.18.2.1 Type I 7.18.2.2 Type II 7.18.2.3 Type III 7.18.3 Capacity, Production, Price, Cost, Gross and Revenue 7.18.4 Contact Information 7.19 Takeda Pharmaceuticals 7.19.1 Company Profile 7.19.2 Product Picture and Specifications 7.19.2.1 Type I 7.19.2.2 Type II 7.19.2.3 Type III 7.19.3 Capacity, Production, Price, Cost, Gross and Revenue 7.19.4 Contact Information 7.20 Vifor Pharma Ltd 7.20.1 Company Profile 7.20.2 Product Picture and Specifications 7.20.2.1 Type I 7.20.2.2 Type II 7.20.2.3 Type III 7.20.3 Capacity, Production, Price, Cost, Gross and Revenue 7.20.4 Contact Information 7.21 Xenetic Biosciences 7.21.1 Company Profile 7.21.2 Product Picture and Specifications 7.21.2.1 Type I 7.21.2.2 Type II 7.21.2.3 Type III 7.21.3 Capacity, Production, Price, Cost, Gross and Revenue 7.21.4 Contact Information 7.22 ZS Pharma 7.22.1 Company Profile 7.22.2 Product Picture and Specifications 7.22.2.1 Type I 7.22.2.2 Type II 7.22.2.3 Type III 7.22.3 Capacity, Production, Price, Cost, Gross and Revenue 7.22.4 Contact Information 8 Price and Gross Margin Analysis 8.1 Analysis of Price 8.2 Gross Margin Analysis 8.3 Price Comparison by Regions 8.4 Price Analysis of Different Chronic Kidney Disease Drug Product Types 8.5 Market Share Analysis of Different Chronic Kidney Disease Drug Price Levels 8.6 Gross Margin Analysis of Different Chronic Kidney Disease Drug Applications 9 Marketing Trader or Distributor Analysis of Chronic Kidney Disease Drug 9.1 Marketing Channels Status of Chronic Kidney Disease Drug 9.2 Traders or Distributors of Chronic Kidney Disease Drug with Contact Information 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Chronic Kidney Disease Drug 9.4 United States Import, Export and Trade Analysis of Chronic Kidney Disease Drug 10 Development Trend of Chronic Kidney Disease Drug Industry 2016-2021 10.1 Capacity and Production Overview of Chronic Kidney Disease Drug 2016-2021 10.2 Production Market Share by Product Types of Chronic Kidney Disease Drug 2016-2021 10.3 Sales and Sales Revenue Overview of Chronic Kidney Disease Drug 2016-2021 10.4 United States Sales of Chronic Kidney Disease Drug by Applications 2016-2021 10.5 Import, Export and Consumption of Chronic Kidney Disease Drug 2016-2021 10.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease Drug 2016-2021 11 Industry Chain Suppliers of Chronic Kidney Disease Drug with Contact Information 11.1 Major Raw Materials Suppliers of Chronic Kidney Disease Drug with Contact Information 11.2 Manufacturing Equipment Suppliers of Chronic Kidney Disease Drug with Contact Information 11.3 Major Players of Chronic Kidney Disease Drug with Contact Information 11.4 Key Consumers of Chronic Kidney Disease Drug with Contact Information 11.5 Supply Chain Relationship Analysis of Chronic Kidney Disease Drug 12 New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug 12.1 New Project SWOT Analysis of Chronic Kidney Disease Drug 12.2 New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug 13 Conclusion of the United States Chronic Kidney Disease Drug Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Chronic Kidney Disease Drug Table Product Specifications of Chronic Kidney Disease Drug Table Classification of Chronic Kidney Disease Drug Figure United States Sales Market Share of Chronic Kidney Disease Drug by Product Types in 2015 Table Applications of Chronic Kidney Disease Drug Figure United States Sales Market Share of Chronic Kidney Disease Drug by Applications in 2015 Figure Industry Chain Structure of Chronic Kidney Disease Drug Table United States Industry Overview of Chronic Kidney Disease Drug Table Industry Policy of Chronic Kidney Disease Drug Table Industry News List of Chronic Kidney Disease Drug Table Bill of Materials (BOM) of Chronic Kidney Disease Drug Table Bill of Materials (BOM) Price of Chronic Kidney Disease Drug Table Labor Cost of Chronic Kidney Disease Drug Table Depreciation Cost of Chronic Kidney Disease Drug Table Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug in 2015 Figure Manufacturing Process Analysis of Chronic Kidney Disease Drug Table United States Price Analysis of Chronic Kidney Disease Drug 2011-2016 (USD/Unit) Table United States Cost Analysis of Chronic Kidney Disease Drug 2011-2016 (USD/Unit) Table United States Gross Analysis of Chronic Kidney Disease Drug 2011-2016 Table Capacity (Unit) and Commercial Production Date of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 Table Manufacturing Plants Distribution of United States Key Chronic Kidney Disease Drug Manufacturers in 2015 Table R&D Status and Technology Source of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 Table Raw Materials Sources Analysis of United States and United States Chronic Kidney Disease Drug Key Manufacturers in 2015 Table United States Production of Chronic Kidney Disease Drug by Regions 2011-2016 (Unit) Table United States Production Market Share of Chronic Kidney Disease Drug by Regions 2011-2016 Figure United States Production Market Share of Chronic Kidney Disease Drug by Regions in 2014 Figure United States Production Market Share of Chronic Kidney Disease Drug by Regions in 2015 Table United States Production of Chronic Kidney Disease Drug by Types in 2011-2016 (Unit) Table United States Production Market Share of Chronic Kidney Disease Drug by Type in 2011-2016 Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2014 Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2015 Table United States Sales of Chronic Kidney Disease Drug by Applications 2011-2016 (Unit) Table United States Production Market Share of Chronic Kidney Disease Drug by Applications 2011-2016 Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2014 Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2015 Table Price Comparison of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 (USD/Unit) Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Chronic Kidney Disease Drug 2011-2016 Table United States Consumption Volume of Chronic Kidney Disease Drug by Regions 2011-2016 (Unit) Table United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions 2011-2016 Figure United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions in 2014 Figure United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions in 2015 Table United States Consumption Value of Chronic Kidney Disease Drug by Regions 2011-2016 (M USD) Table United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions 2011-2016 Figure United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions in 2014 Figure United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions in 2015 Table Consumption Price of Chronic Kidney Disease Drug by Regions 2011-2016 (USD/Unit) Table United States and Major Manufacturers Capacity of Chronic Kidney Disease Drug 2011-2016 (Unit) Table United States Capacity Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016 Table United States and Major Manufacturers Production of Chronic Kidney Disease Drug 2011-2016 (Unit) Table United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016 Table United States and Major Manufacturers Sales of Chronic Kidney Disease Drug 2011-2016 (Unit) Table United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016 Table United States and Major Manufacturers Sales Revenue of Chronic Kidney Disease Drug 2011-2016 (M USD) Table United States Sales Revenue Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016 Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Chronic Kidney Disease Drug 2011-2016 Figure United States Capacity Utilization Rate of Chronic Kidney Disease Drug 2011-2016 Figure United States Sales Revenue (M USD) and Growth Rate of Chronic Kidney Disease Drug 2011-2016 Figure United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2014 Figure United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2015 Figure United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2014 Figure United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2015 Figure United States Sales (Unit) and Growth Rate of Chronic Kidney Disease Drug 2011-2016 Table United States Supply, Consumption and Gap of Chronic Kidney Disease Drug 2011-2016 (Unit) Table United States Import, Export and Consumption of Chronic Kidney Disease Drug 2011-2016 (Unit) Table Price of United States Chronic Kidney Disease Drug Major Manufacturers 2011-2016 (USD/Unit) Table Gross Margin of United States Chronic Kidney Disease Drug Major Manufacturers 2011-2016 Table United States and Major Manufacturers Revenue of Chronic Kidney Disease Drug 2011-2016 (M USD) Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease Drug 2011-2016 Table Actavis PLC Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Actavis PLC Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Actavis PLC 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Actavis PLC 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Actavis PLC 2011-2016 Table Actavis PLC Chronic Kidney Disease Drug SWOT Analysis Table Amgen Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Amgen Inc. Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen Inc. 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Amgen Inc. 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Amgen Inc. 2011-2016 Table Amgen Inc. Chronic Kidney Disease Drug SWOT Analysis Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Johnson & Johnson Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Johnson & Johnson 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Johnson & Johnson 2011-2016 Table Johnson & Johnson Chronic Kidney Disease Drug SWOT Analysis Table F. Hoffmann-La Roche Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of F. Hoffmann-La Roche Ltd Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche Ltd 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of F. Hoffmann-La Roche Ltd 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of F. Hoffmann-La Roche Ltd 2011-2016 Table F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drug SWOT Analysis Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Sanofi Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Sanofi 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Sanofi 2011-2016 Table Sanofi Chronic Kidney Disease Drug SWOT Analysis Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Abbott Laboratories Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Abbott Laboratories 2011-2016 Table Abbott Laboratories Chronic Kidney Disease Drug SWOT Analysis Table Akebia Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Akebia Therapeutics Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Akebia Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Akebia Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Akebia Therapeutics 2011-2016 Table Akebia Therapeutics Chronic Kidney Disease Drug SWOT Analysis Table AMAG Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of AMAG Pharmaceuticals Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AMAG Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of AMAG Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of AMAG Pharmaceuticals 2011-2016 Table AMAG Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis Table Cara Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Cara Therapeutics Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cara Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Cara Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Cara Therapeutics 2011-2016 Table Cara Therapeutics Chronic Kidney Disease Drug SWOT Analysis Table FibroGen Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of FibroGen Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of FibroGen 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of FibroGen 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of FibroGen 2011-2016 Table FibroGen Chronic Kidney Disease Drug SWOT Analysis Table Keryx Biopharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Keryx Biopharmaceuticals Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Keryx Biopharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Keryx Biopharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Keryx Biopharmaceuticals 2011-2016 Table Keryx Biopharmaceuticals Chronic Kidney Disease Drug SWOT Analysis Table Reata Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Reata Pharmaceuticals Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Reata Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Reata Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Reata Pharmaceuticals 2011-2016 Table Reata Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis Table OPKO Health Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of OPKO Health Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of OPKO Health 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of OPKO Health 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of OPKO Health 2011-2016 Table OPKO Health Chronic Kidney Disease Drug SWOT Analysis Table Pharmacosmos Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Pharmacosmos Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pharmacosmos 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Pharmacosmos 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Pharmacosmos 2011-2016 Table Pharmacosmos Chronic Kidney Disease Drug SWOT Analysis Table Raptor Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Raptor Pharmaceuticals Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Raptor Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Raptor Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Raptor Pharmaceuticals 2011-2016 Table Raptor Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis Table Regulus Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Regulus Therapeutics Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Regulus Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Regulus Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Regulus Therapeutics 2011-2016 Table Regulus Therapeutics Chronic Kidney Disease Drug SWOT Analysis Table Rockwell Medical Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Rockwell Medical Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Rockwell Medical 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Rockwell Medical 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Rockwell Medical 2011-2016 Table Rockwell Medical Chronic Kidney Disease Drug SWOT Analysis Table Shield Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Shield Therapeutics Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shield Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Shield Therapeutics 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Shield Therapeutics 2011-2016 Table Shield Therapeutics Chronic Kidney Disease Drug SWOT Analysis Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Takeda Pharmaceuticals Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Takeda Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Takeda Pharmaceuticals 2011-2016 Table Takeda Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis Table Vifor Pharma Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Vifor Pharma Ltd Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Vifor Pharma Ltd 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Vifor Pharma Ltd 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Vifor Pharma Ltd 2011-2016 Table Vifor Pharma Ltd Chronic Kidney Disease Drug SWOT Analysis Table Xenetic Biosciences Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of Xenetic Biosciences Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Xenetic Biosciences 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Xenetic Biosciences 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Xenetic Biosciences 2011-2016 Table Xenetic Biosciences Chronic Kidney Disease Drug SWOT Analysis Table ZS Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease Drug Picture and Specifications of ZS Pharma Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ZS Pharma 2011-2016 Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of ZS Pharma 2011-2016 Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of ZS Pharma 2011-2016 Table ZS Pharma Chronic Kidney Disease Drug SWOT Analysis Table Chronic Kidney Disease Drug Price by Regions 2011-2016 Table Chronic Kidney Disease Drug Price by Product Types 2011-2016 Table Chronic Kidney Disease Drug Price by Companies 2011-2016 Table Chronic Kidney Disease Drug Gross Margin by Companies 2011-2016 Table Price Comparison of Chronic Kidney Disease Drug by Regions 2011-2016 (USD/Unit) Table Price of Different Chronic Kidney Disease Drug Product Types (USD/Unit) Table Market Share of Different Chronic Kidney Disease Drug Price Level Table Gross Margin of Different Chronic Kidney Disease Drug Applications Table Marketing Channels Status of Chronic Kidney Disease Drug Table Traders or Distributors of Chronic Kidney Disease Drug with Contact Information Table Ex-work Price, Channel Price and End Buyer Price of Chronic Kidney Disease Drug (USD/Unit) in 2015 Table United States Import, Export, and Trade of Chronic Kidney Disease Drug (Unit) Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Chronic Kidney Disease Drug 2016-2021 Figure United States Capacity Utilization Rate of Chronic Kidney Disease Drug 2016-2021 Table United States Chronic Kidney Disease Drug Production by Type 2016-2021 (Unit) Table United States Chronic Kidney Disease Drug Production Market Share by Type 2016-2021 Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2021 Figure United States Sales (Unit) and Growth Rate of Chronic Kidney Disease Drug 2016-2021 Figure United States Sales Revenue (Million USD) and Growth Rate of Chronic Kidney Disease Drug 2016-2021 Figure United States Sales of Chronic Kidney Disease Drug by Applications 2016-2021 (Unit) Table United States Production Market Share of Chronic Kidney Disease Drug by Applications 2016-2021 Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2021 Table United States Production, Import, Export and Consumption of Chronic Kidney Disease Drug 2016-2021 (Unit) Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease Drug 2016-2021 Table Major Raw Materials Suppliers of Chronic Kidney Disease Drug with Contact Information Table Manufacturing Equipment Suppliers of Chronic Kidney Disease Drug with Contact Information Table Major Players of Chronic Kidney Disease Drug with Contact Information Table Key Consumers of Chronic Kidney Disease Drug with Contact Information Table Supply Chain Relationship Analysis of Chronic Kidney Disease Drug Table New Project SWOT Analysis of Chronic Kidney Disease Drug Table New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug Table Part of Interviewees Record List



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...
Choose License Type
Single User - US $3800
Multi User - US $7600
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify